Semaglutide Weight Loss Plateau: Short Stall vs Sustained Plateau

A scale that holds for a couple weeks on semaglutide often reflects a normal pause. Visible loss usually starts within 1 to 2 months and builds over 6 to 12 months or longer onset timeline, and trial weight loss was sustained over two years two-year trial results. A flat trend that lasts longer while your eating, activity and hunger control stay steady points more toward a plateau at a lower weight. Your notes on hunger, intake, dose stage and how long the stall lasted show whether to adjust daily habits, ask your prescriber about dose, or stay the course.

How can I tell a short stall from a true plateau?

Early slow progress fits the usual pattern. In real world records, average loss at 8 weeks was about 1.1% of starting weight onset timeline, so small early changes fit expected timing rather than loss of effect. In a 2 year trial of semaglutide 2.4 mg with lifestyle support, average weight loss was sustained through week 104 two-year trial results.

Read the trend across weeks rather than single weigh-ins. A short stall shows as readings that move up and down around the same weight for a few weeks, then movement resumes. A plateau shows as little movement over a longer stretch even though meals, drinks, sleep and activity stayed consistent. Those trial averages came from adults who also received diet and activity counseling, so they describe what happened in that setting rather than what every woman will see.

What details change what I do next?

A practical check used in weight care separates three situations reasons for stalled loss. First, your intake now matches what your smaller body uses. You eat fewer calories than your body uses to lose weight, and that gap narrows as you lose. Second, your body settled at a lower weight. You feel full on your current amount, habits stayed steady, yet weight holds. Third, your current prescribed amount leaves hunger strong. You think about food often, portions grew, and eating less feels hard.

Each pattern points a different way. Rising hunger and larger portions point to intake and daily routine. Steady fullness with steady habits points to adaptation at the new weight. Strong persistent hunger while your prescribed amount is still increasing points to dose stage, which your prescriber reviews.

When should I reassess my plan?

Bring your recent pattern to your prescriber before you pause or stop. In the STEP 1 follow up, participants regained about two thirds of lost weight within a year after stopping semaglutide and lifestyle support, and health measures moved back toward starting levels withdrawal results. Reviewing dose, eating and activity while you stay on treatment protects progress better than stopping during a flat stretch. Bring your weight trend plus notes on meals, activity, hunger and your current prescribed amount. If you want HOD to review your pattern for a weight loss plan, start with the quiz.